A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease. JAMA Neurol 2013;70:25-33. | USF Parkinson's Disease and Movement Disorders Center

Group. , Horizon Investigators of the Huntington Study. 2013. “A Randomized, Double-Blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease. JAMA Neurol 2013;70:25-33.”. JAMA Neurol.

Last updated on 10/03/2024